Angelini Pharma

https://www.angelinipharma.com

Angelini Pharma is an international pharmaceutical company, part of the Italian privately-owned Angelini Group. Angelini Pharma is committed to helping patients in the therapeutics areas of Central Nervous System and Mental Health (including Pain), Rare Diseases and Consumer Healthcare. Over the past 50 years, in the field of mental health, Angelini Pharma has gained international recognition for its substantial efforts to improve the management of patients with mental health disorders thanks to important, internally developed, molecules (such as trazodone) and its commitment to fighting mental health stigma. Angelini Pharma operates directly in 20 countries employing almost 3.000 people and commercializes its products in more than 50 countries through strategic alliances with leading international pharmaceutical groups. *

	Start	2021-03-02 existent
	Group	Angelini (Group)
	Industry	pharmaceutical
	Industry 2	CNS drug (neurological drug)
	Person	Antonelli, Pierluigi (Angelini 202103 CEO of Angelini Pharma)

	City	n. a.
		Address record changed: 2021-12-18

Basic data	Employees	n. a.

		* Document for »About Section«: Argobio SAS. (3/2/21). "Press Release: Argobio Announces Its Launch with 50 M€ to Create and Develop Pioneering Biotech Spinouts with the Support of Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur". Paris.

		Record changed: 2023-07-10